Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America.
Clemente WT, Pierrotti LC, Abdala E, Morris MI, Azevedo LS, López-Vélez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, Wright AJ, Beeching NJ, Vilela EG, Santoro-Lopes G, Len O, Stucchi RSB, Manuel O, Faria LC, Leblebicioglu H, Huprikar S, Molina I, Mourão PHO, Kotton CN, Aguado JM; working group on Endemic Disease and Travel Medicine in Solid-Organ Transplantation. Clemente WT, et al. Among authors: leblebicioglu h. Transplantation. 2018 Feb;102(2):193-208. doi: 10.1097/TP.0000000000002027. Transplantation. 2018. PMID: 29381647 Review.
Barriers to access to hepatitis C treatment.
Yilmaz H, Yilmaz EM, Leblebicioglu H. Yilmaz H, et al. Among authors: leblebicioglu h. J Infect Dev Ctries. 2016 Apr 28;10(4):308-16. doi: 10.3855/jidc.7849. J Infect Dev Ctries. 2016. PMID: 27130991 Free article. Review.
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries.
Leblebicioglu H, Arama V, Causse X, Marcellin P, Ozaras R, Postawa-Klozinska B, Simon K, Suceveanu AI, Wiese M, Zeuzem S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zarski JP; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Leblebicioglu H, et al. J Viral Hepat. 2014;21(9):662-70. doi: 10.1111/jvh.12202. Epub 2013 Dec 15. J Viral Hepat. 2014. PMID: 24329883
Hepatitis E virus infection in Turkey: a systematic review.
Leblebicioglu H, Ozaras R. Leblebicioglu H, et al. Ann Clin Microbiol Antimicrob. 2018 May 2;17(1):17. doi: 10.1186/s12941-018-0269-6. Ann Clin Microbiol Antimicrob. 2018. PMID: 29716597 Free PMC article. Review.
Medical Considerations before International Travel.
Ozaras R, Leblebicioglu H. Ozaras R, et al. Among authors: leblebicioglu h. N Engl J Med. 2016 Oct 13;375(15):e32. doi: 10.1056/NEJMc1610671. N Engl J Med. 2016. PMID: 27732816 No abstract available.
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.
Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID). Leblebicioglu H, et al. Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5. Antiviral Res. 2018. PMID: 29217468
169 results